Department of Hematology, Huashan Hospital, Shanghai Medical College, Fudan University, 12 Urumqi Road Middle, 200040 Shanghai, China.
Leuk Res. 2010 Apr;34(4):458-62. doi: 10.1016/j.leukres.2009.07.011. Epub 2009 Jul 24.
To investigate clinical characteristic and prognostic factors for chronic myelomonocytic leukemia (CMML).
A retrospective cohort study was used in the research. We investigated clinical and laboratory characteristics of CMML patients and survival status. Patients were followed up regularly through out the course of the research.
Forty-one cases were diagnosed as CMML, including 27 male and 14 female patients. Median WBC was 13.7 x 10(9)/L. Five patients had leukocytopenia (1.92-3.46 x 10(9)/L). Median monocyte count in the peripheral blood was 2.13 x 10(9)/L. All patients presented with bone marrow dysplasia, and most showed hyperplasia, except 3 cases. Abnormal chromosome was detected in 34% cases. Median survival time for CMML-1 and CMML-2 was 20 and 12 months, respectively, but there were no statistical significance of survival duration between them. Univariable analysis showed that age (>60 years), neutrophil count (<2.0 x 10(9)/L), lymphocyte count (<1.0 x 10(9)/L), mature monocyte count (>or=5 x 10(9)/L) and anemia (Hb<60 g/L) were associated with poor prognosis for CMML. There was no statistical significance in LDH, gender, and abnormal chromosome for survival time. Only lymphocyte count and neutrophil count in peripheral blood were independent prognostic factors for CMML after multivariate analysis.
CMML mainly occurs in elderly patients. Although most patients have leukocytosis and monocytosis at diagnosis, few cases show leucopenia and monocytopenia. Age, neutrophil, lymphopenia, monocytosis, and severe anemia are associated with inferior prognosis of CMML. Lymphocyte<1.0 x 10(9)/L and neutrophil count<2.0 x 10(9)/L are adversely independent prognostic factors for CMML.
研究慢性髓单核细胞白血病(CMML)的临床特征和预后因素。
本研究采用回顾性队列研究。我们研究了 CMML 患者的临床和实验室特征以及生存状况。通过研究过程中的定期随访来跟踪患者。
诊断为 CMML 的 41 例患者中,男 27 例,女 14 例。中位白细胞计数为 13.7 x 10(9)/L。5 例患者白细胞减少(1.92-3.46 x 10(9)/L)。外周血单核细胞计数中位数为 2.13 x 10(9)/L。所有患者均存在骨髓增生异常,除 3 例外,大多数表现为增生,异常染色体在 34%的病例中被检测到。CMML-1 和 CMML-2 的中位生存时间分别为 20 个月和 12 个月,但两者的生存时间无统计学差异。单变量分析表明,年龄(>60 岁)、中性粒细胞计数(<2.0 x 10(9)/L)、淋巴细胞计数(<1.0 x 10(9)/L)、成熟单核细胞计数(>或=5 x 10(9)/L)和贫血(Hb<60 g/L)与 CMML 预后不良相关。乳酸脱氢酶(LDH)、性别和异常染色体与生存时间无统计学意义。多变量分析后,仅外周血淋巴细胞计数和中性粒细胞计数是 CMML 的独立预后因素。
CMML 主要发生在老年患者中。虽然大多数患者在诊断时存在白细胞增多和单核细胞增多,但少数病例存在白细胞减少和单核细胞减少。年龄、中性粒细胞、淋巴细胞减少、单核细胞增多和严重贫血与 CMML 的不良预后相关。淋巴细胞<1.0 x 10(9)/L 和中性粒细胞计数<2.0 x 10(9)/L 是 CMML 的不利独立预后因素。